Science Weekly Titelbild

Science Weekly

Science Weekly

Von: The Guardian
Jetzt kostenlos hören, ohne Abo

Twice a week, the Guardian brings you the latest science and environment news© 2026 Guardian News & Media Limited or its affiliated companies. All rights reserved. Wissenschaft
Folgen
  • The audacious plan to refreeze the Arctic

    The audacious plan to refreeze the Arctic
    Jun 18 2026
    Sea ice is melting fast and worsening the climate crisis. But what if there were a way to thicken it again? Madeleine Finlay is joined by environment editor Damian Carrington to discuss a bold attempt to refreeze the Arctic which is showing early signs of success. He visited the project to find out how it will work, how much it will cost and whether it really has potential to improve the fate of the Arctic’s ice. Help support our independent journalism at theguardian.com/sciencepod
    Mehr anzeigen Weniger anzeigen
    16 Min.
  • Should we ban social media for under-16s?

    Should we ban social media for under-16s?
    Jun 15 2026
    The UK prime minister, Keir Starmer, has announced a social media ban for under-16s, as part of an online safety drive that aims to go even further than the world’s first ban, introduced by Australia last year. Many parents have welcomed the proposals, but scientists have pointed to the lack of strong evidence for the efficacy of bans, and some campaigners have argued that the proposal allows social media companies to avoid making meaningful changes on their platforms. Ian Sample is joined by co-host Madeleine Finlay to explore what the evidence indicates about the harms of social media and the impact of banning it outright. Help support our independent journalism at theguardian.com/sciencepod
    Mehr anzeigen Weniger anzeigen
    20 Min.
  • ‘The undruggable became druggable’: a gamechanging treatment for the world’s deadliest cancer

    ‘The undruggable became druggable’: a gamechanging treatment for the world’s deadliest cancer
    Jun 11 2026
    A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients, Madeleine Finlay speaks to Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital. Help support our independent journalism at theguardian.com/sciencepod
    Mehr anzeigen Weniger anzeigen
    15 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden